SUBSCRIBE
SUBSCRIBE

Rezolute, Inc.

NEWS
Woman With Pipette And Test Tubes
Drug Development
Clinical Catch-Up: Moderna COVID-19 Vaccine for Kids and Much More
Although it was relatively quiet in COVID-19-related clinical trials, there was plenty of other clinical trial news. Here’s a look.
March 25, 2022
 · 
10 min read
 · 
Mark Terry
Business
BioSpace Movers & Shakers, March 12
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
March 11, 2021
 · 
7 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Biotech Bay
Rezolute, Inc. Announces Closing of Registered Direct Offering - May 04, 2022
May 4, 2022
 · 
6 min read
Drug Development
Rezolute Announces Positive Data from its Phase 2b (RIZE) Study of RZ358 in Patients with Congenital Hyperinsulinism
May 1, 2022
 · 
12 min read
Biotech Bay
RZ358 Phase 2b (RIZE Study) Topline Data to be Unveiled at Pediatric Endocrine Society Annual Meeting on May 1, 2022
April 26, 2022
 · 
4 min read
Business
Rezolute Joins the Rare Disease Company Coalition
March 29, 2022
 · 
2 min read
Drug Development
Rezolute Announces Positive Results from the Phase 2b RIZE Study of RZ358 in Congenital Hyperinsulinism
March 23, 2022
 · 
5 min read
Drug Development
Rezolute Announces Positive Study Results for RZ402, an oral PKI being developed for DMEPhase 2 proof-of-concept study anticipated in 2H 2022
February 22, 2022
 · 
7 min read
Drug Development
Rezolute Reports Second Quarter Fiscal 2022 Financial Results and Highlights Company ProgressTopline results from RZ358 Phase 2b and RZ402 Phase 1b studies expected before the end of Q1 2022
February 9, 2022
 · 
4 min read
Business
Rezolute Reports First Quarter Fiscal 2022 Financial Results and Highlights Recent Company Progress
November 12, 2021
 · 
5 min read
Biotech Bay
Rezolute Announces Pricing of Public Offering of $55 million of Common Stock and Pre-Funded Warrants, and Concurrent Registered Direct Offering
October 13, 2021
 · 
5 min read
Biotech Bay
Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants, and a Concurrent Registered Direct Offering
October 12, 2021
 · 
5 min read
Load More